Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Metastatic Adenocarcinoma of the Pancreas”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Very early researchStudy completedNCT00436410
What this trial is testing

Tumor Necrosis Factor in Patients Undergoing Surgery for Primary Cancer or Metastatic Cancer

Who this might be right for
Adrenocortical CarcinomaBreast CancerColorectal Cancer+7 more
National Institutes of Health Clinical Center (CC) 108
Testing effectiveness (Phase 2)Study completedNCT00161213
What this trial is testing

Gemcitabine and Imatinib Mesylate as First-Line Therapy in Patients With Locally Adv. or Metastatic Pancreatic Cancer

Who this might be right for
Pancreatic Cancer
University of Medicine and Dentistry of New Jersey 44
Early research (Phase 1)Study completedNCT00019513
What this trial is testing

Combination Chemotherapy in Treating Patients With Recurrent, Refractory, or Metastatic Solid Tumors or Lymphomas

Who this might be right for
Colorectal CancerEsophageal CancerExtrahepatic Bile Duct Cancer+7 more
National Institutes of Health Clinical Center (CC) 108
Early research (Phase 1)WithdrawnNCT02567396
What this trial is testing

Talazoparib in Treating Patients With Advanced or Metastatic Solid Tumors That Cannot Be Removed by Surgery and Liver or Kidney Dysfunction

Who this might be right for
Estrogen Receptor NegativeHead and Neck Squamous Cell CarcinomaHER2/Neu Negative+20 more
National Cancer Institute (NCI)
Not applicableLooking for participantsNCT06524973
What this trial is testing

Telehealth Self-Management Coaching Sessions to Improve Quality of Life in Pancreatic Cancer Survivors and Their Family Care Givers

Who this might be right for
Metastatic Pancreatic Adenocarcinoma
City of Hope Medical Center 136
Early research (Phase 1)Looking for participantsNCT07030283
What this trial is testing

Intraperitoneal Paclitaxel With NALIRIFOX for Pancreatic Ductal Adenocarcinoma With Peritoneal Carcinomatosis

Who this might be right for
Pancreatic Ductal Adenocarcinoma (PDAC)
University of Colorado, Denver 10
Testing effectiveness (Phase 2)Study completedNCT00226005
What this trial is testing

PTK787 in Patients With Advanced Metastatic Pancreatic Adenocarcinoma

Who this might be right for
Neoplasm
Pancreatic Cancer Research Team 67
Testing effectiveness (Phase 2)UnknownNCT02329717
What this trial is testing

Efficacy and Safety Study of PBI-05204 in Patients With Stage IV Metastatic Pancreatic Adenocarcinoma

Who this might be right for
Pancreatic Cancer
Phoenix Biotechnology, Inc 50
Early research (Phase 1)Study completedNCT03329950
What this trial is testing

CDX-1140 (CD40) as Monotherapy or in Combination in Patients With Advanced Malignancies

Who this might be right for
MelanomaNon-small Cell Lung CancerBreast Cancer+23 more
Celldex Therapeutics 132
Testing effectiveness (Phase 2)Study completedNCT00003591
What this trial is testing

Radiation Therapy Plus Paclitaxel in Treating Patients With Nonmetastatic, Unresectable Pancreatic Cancer

Who this might be right for
Pancreatic Cancer
Radiation Therapy Oncology Group 122
Not applicableLooking for participantsNCT06065891
What this trial is testing

Para-aortic Lymph Node Metastasis in Resectable Pancreatic Cancer

Who this might be right for
Pancreas CancerPancreas AdenocarcinomaLymph Node Metastasis
Jon Unosson 300
Large-scale testing (Phase 3)Study completedNCT00016380
What this trial is testing

Ondansetron With/Out Dexamethasone to Prevent Vomiting in Patients Receiving Radiation to the Upper Abdomen

Who this might be right for
Cancer
NCIC Clinical Trials Group 211
Large-scale testing (Phase 3)Looking for participantsNCT06998940
What this trial is testing

Studying Chemotherapy With or Without Panitumumab for Unresectable, Locally Advanced, or Metastatic Pancreatic Cancer Without KRAS Mutations

Who this might be right for
Locally Advanced Pancreatic AdenocarcinomaMetastatic Pancreatic AdenocarcinomaStage III Pancreatic Cancer AJCC v8+2 more
SWOG Cancer Research Network 94
Testing effectiveness (Phase 2)Study completedNCT00003810
What this trial is testing

Combination Chemotherapy in Treating Patients With Locally Advanced or Metastatic Cancer of the Pancreas

Who this might be right for
Pancreatic Cancer
Eastern Cooperative Oncology Group
Testing effectiveness (Phase 2)Active Not RecruitingNCT02498613
What this trial is testing

Cediranib in Combination With Olaparib in Advanced Solid Tumors

Who this might be right for
Advanced Malignant Solid NeoplasmMetastatic Lung Non-Small Cell CarcinomaMetastatic Lung Small Cell Carcinoma+23 more
National Cancer Institute (NCI) 122
Large-scale testing (Phase 3)Ended earlyNCT02119663
What this trial is testing

Ruxolitinib in Pancreatic Cancer Patients

Who this might be right for
Pancreatic Cancer
Incyte Corporation 86
Testing effectiveness (Phase 2)Study completedNCT04769414
What this trial is testing

Flouro-Gem in Adenocarcinoma of the Pancreas (GEFLUPAN)

Who this might be right for
Cancer of PancreasChemotherapy EffectMetastatic Pancreatic Cancer
Menoufia University 48
Not applicableNo Longer AvailableNCT07399015
What this trial is testing

Expanded Access to Mifomelatide for Cachexia in Adults With Advanced PDAC

Who this might be right for
Pancreatic Ductal Adenocarcinoma (mPDAC)Unresectable Pancreatic Ductal AdenocarcinomaMetastatic PDAC
Endevica Bio
Testing effectiveness (Phase 2)Ended earlyNCT03213626
What this trial is testing

Cabozantinib and Erlotinib for Patients With EGFR and c-Met Co-expressing Metastatic Pancreatic Adenocarcinoma

Who this might be right for
Pancreatic Adenocarcinoma Metastatic
Patrick Joseph Loehrer Sr. 7
Testing effectiveness (Phase 2)Study completedNCT00637247
What this trial is testing

Study of Amplimexon (Imexon) With Gemcitabine in Pancreatic Cancer

Who this might be right for
Pancreatic Neoplasms
AmpliMed Corporation 142
Next Page